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Objective: to analyze the rates of maternal mortality due to hemorrhage identified in Brazil 
from 1997 to 2009. Methods: the time series and population data from the Brazilian Health 
Ministry, Mortality Information System and Live Birth Information System were examined. From 
the Mortality Information System, we initially selected all reported deaths of women between 
10 and 49 years old, which occurred from January 1, 1997 to December 31, 2009 in Brazil, 
recorded as a “maternal death”. Results: during the research period, 22,281 maternal deaths 
were identified, among which 3,179 were due to hemorrhage, accounting for 14.26% of the total 
deaths. The highest rates of maternal mortality were found in the North and Northeast areas 
of Brazil. Conclusions: the Brazilian scenario shows regional inequalities regarding maternal 
mortality. It presents hemorrhaging as a symptom and not as a cause of death.
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Introduction
Maternal Mortality (MM) is defined as the death of 
a woman during pregnancy or within a period of 42 days 
after termination of pregnancy, regardless of duration 
or site of the pregnancy, from any cause related to 
or aggravated by pregnancy or its management, but 
not due to accidental or incidental causes. Obstetric 
Maternal Mortality, more specifically, is related to 
obstetric complications during pregnancy, childbirth or 
the puerperium, due to interventions, omissions and 
incorrect treatment, or chains of events arising from any 
such causes. These correspond to deaths that in Brazil 
are coded CID-10 as: O00.0 - O08.9, O11 - O23.9, 
O24.4 - O26, 92.7, E23.0, F53 and M83.0(1-4).
In general, MM suggests a death that occurs 
prematurely, with causes considered to be avoidable, 
reflecting not only on the living conditions of women, 
but also on the level of organization and quality of care 
provided(4-5).
There are many issues related to Maternal Mortality 
based on both empirical and theoretical information. 
However, despite the number of published papers on 
the subject, MM, which is preventable, continues to 
occur at high rates, a reality that needs to be transformed 
urgently(4-7).
Hemorrhage is a major cause of avoidable maternal 
death worldwide and it includes ante-partum, intra-
partum and postpartum hemorrhaging(8). In developing 
countries, the main cause of MM is postpartum 
hemorrhage, which affects about 1% of pregnant 
women, with overall MM rates ranging from 290-450(1). 
In more developed countries, such as France, the MM 
rate is lower, but has remained around 10 per 100,000 
births, and hemorrhage is still one of the main causes 
observed(8-10). In the United States, recent MM rates 
are reported at 13.3 - 24 per 100,000 live births, with 
an increasing trend in deaths related to postpartum 
hemorrhage(1,11).
In Brazil, MM has been reported from 52 to 75 per 
100,000 live births; published data from 2007 suggest 
that 23% of maternal deaths were due to hypertensive 
diseases and 8% due to hemorrhage(12-13).
Among the principal causes of bleeding were: 
abortion, abruptio placentae, placenta previa, ruptured 
uterus, trauma, coagulopathy, and postpartum 
hemorrhage. The last is considered preventable with 
adequate obstetrical support(13).
The objective of this study is to analyze the Maternal 
Mortality Ratio (MMR) by hemorrhage, in Brazil, during 
the period 1997 to 2009. The measurement of MMR as 
the result of hemorrhage provides information to health 
managers in planning actions aimed at reducing it. Thus, 
without this information it would be impossible to meet 
the Millennium development goals to which Brazil is a 
signatory(14). 
Method
This is a descriptive study of a retrospective record 
review, population-based series, from data provided by 
the Ministry of Health of Brazil, the Mortality Information 
System (SIM) and the Live Birth Information System 
(SINASC). From the SIM we initially selected all reported 
deaths of women between 10 and 49 years old, which 
occurred from January 1st of 1997 to December 31st 
of 2009 in Brazil and recorded as a “maternal death,” 
whose root cause was a maternal condition related to 
hemorrhage. Thus, for the study sample, this included 
all cases reported in the following categories of CID-
10:2: 000 – ectopic pregnancy; O20 – early pregnancy 
bleeding; O43 –malformations of the placenta; O44 
– placenta previa; O45 – abruptio placentae; O46 – 
antepartum hemorrhage; NCOP, O67 – complicated labor 
intra-partum hemorrhage; and NCOP, O72 – postpartum 
hemorrhage(3). Exclusion criteria included maternal 
deaths related to hemorrhage due to abortion, because 
the records contained in the SIM do not permit us to 
evaluate if this death is associated with a hemorrhagic 
event, infection, or other cause. We also excluded cases 
coded as O96 and O97 - late maternal death (deaths 
that occur 43-365 days postpartum) resulting from 
obstetric causes.
The data concerning the total live births during the 
study period were collected from SINASC.
Descriptive analysis was used to determine the 
distribution and frequency of cases of MM collected from 
the SIM data, in accord with the aforementioned inclusion 
and exclusion criteria. Then we calculated Maternal 
Mortality Ratio (MMR) corrected according to adjustment 
factors(15) comparing the calculation of MMR with and 
without correction(15) for each region of the country 
during the study period. Standardized adjustment factors 
are used to take into account potential underestimations 
and misclassifications of maternal deaths in registered 
reports and based on a literature review of previously 
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published reports. The MMR is defined as the relationship 
between the maternal deaths divided by the total of live 
births, multiplied by 100,000:
due to complications in pregnancy, childbirth or the 
post-partum period (i.e., maternal deaths). Out of this 
total, 3,179 (14.2%) were associated with hemorrhage. 
Table 1 shows the number of cases, for each year of the 
period, as it appears on the SIM, and the total number 
of cases, after applying the correction factor(15), which 
brings the total to 3,609.
It was also noted that postpartum hemorrhage 
(CID O72), and abruptio placentae (CID O45) were 
the two leading cause of maternal death due to 
hemorrhage, accounting for 41 and 30 percent of the 
total, respectively (Figure 1).
Category CID-10 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total %
O00 Ectopic pregnancy 26 23 30 27 25 22 36 28 39 30 40 31 44 401 12.6
O20 Early pregnancy bleeding 1 1 0 0 - - 1 2 2 1 1 3 - 12 0.38
O43 Malformations of the placenta 2 3 1 1 2 1 1 1 - - 3 2 4 21 0.66
O44 Placenta previa 17 12 20 18 12 10 14 15 16 14 12 9 19 188 5.91
O45 Abruptio placentae 96 77 96 82 99 78 70 66 59 71 64 57 58 973 30.6
O46 Antepartum hemorrhage 10 14 14 17 15 11 13 13 14 12 12 17 17 179 5.63
O67 Intrapartum hemorrhage 4 9 8 10 7 10 11 5 6 10 10 9 10 109 3.43
O72 Postpartum hemorrhage 107 97 124 92 83 117 91 105 105 101 109 76 89 1,296 40.8
Total (original number) 263 236 293 247 243 249 237 235 241 239 251 204 241 3,179 100
Applied correction factor* 313 281 349 294 289 296 282 280 287 284 299 243 287 3,784 -
MMR/correction factor* 10.34 8.92 10.71 9.17 9.28 9.68 9.28 9.25 9.46 9.64 10.34 8.28 9.96 - -
Figure 1 - Maternal Mortality due to hemorrhage 
according to category CID 10. Brazil, 1997–2009
Table 1 - Maternal Mortality due to hemorrhage according to category CID-10. Brazil, 1997-2009
* Correction Factor(15).
During the study period, the overall MMRH ranged 
from 10.34 in 1997 to 9.96 in 2009. We observed that 
the Maternal Mortality Ratio by Hemorrhage (MMRH) in 
the north ranged from 7.18 to 12.73/100,000 live births, 
while in the Northeast it was 8.42 to 13.07, in the South, 
from 6.49 to 11.64 and in the Mid-west, from 5.71 to 
11.05 (Figures 2 and 3, Table 2).
We used the World Health Organization definition 
of live birth (i.e., those that were born live, at whatever 
gestational age, and breathes or show any sign of life 
such as, heartbeat, pulsation in the umbilical cord 
or voluntary movements, regardless of whether the 
umbilical cord or placenta are intact)(3).
The study was developed as part of a larger 
project, “Catarinas: birth, life, and death,” approved by 
the Ethics Committee of the Federal University of Santa 
Catarina (CEPSH-UFSC), protocol number 209/2008, 
in observance of resolution number 196/1996, of the 
Ministry of Health of Brazil.
Results
During the study period the SIM identified 22,281 
deaths of women of childbearing age (10 to 49 years) 
Total of maternal deaths
Total of live birth
x 100,000MMR = 
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Table 2 - Maternal Mortality Rates by Region, adjusted by correction factor. Brazil, 1997-2009
Figure 2 - Maternal mortality due to hemorrhage, original values. Brazil, 1997-2009
Figure 3 - Maternal mortality due to hemorrhage, adjusted by correction factor. Brazil, 1997-
2009
Year Brazil North Northeast Southeast South Midwest
1997 10.34 9.69 13.09 9.73 7.85 9.92
1998 8.92 9.76 10.02 8.50 7.18 16.23
1999 10.71 9.11 9.94 11.25 9.78 16.42
2000 9.17 9.97 9.72 8.42 9.53 9.02
2001 9.28 12.69 9.34 9.18 6.97 8.35
2002 9.68 9.63 11.29 7.28 11.57 11.00
2003 9.28 11.88 9.89 8.47 6.42 11.06
2004 9.25 7.44 12.19 8.23 8.28 5.66
(continue...)
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Discussion
Maternal Mortality Rates due to hemorrhage, 
when calculated for each year of the series, proved to 
be identical between regions, common every year, and 
showed little improvement over time, especially in the 
North and Northeast regions. These findings suggest 
that managers and health professionals should invest 
additional attention in the problem of hemorrhaging in 
order to assess technologies and procedures that are 
being adopted, as well as to implement new management 
practices to improve the safety of patients, particularly 
in this areas(16-17).
Regional disparities
MM by hemorrhage was common in all Brazilian 
regions, though more prevalent in the North and 
Northeast, pointing also to the regional differences. In 
general, the level and trends of MM in Brazil may be 
related to socioeconomic differences and unequal access 
to health services between the less affluent regions 
(North and Northeast) and the most affluent regions 
(South and Southeast). Regional disparities in MM have 
also been noted in other countries. In the United States 
MM rates range from 1.2 in the state of Maine to 20.5 in 
the state of Georgia(10).
Exploring the underlying cause
It was considered important to explore the 
causes of hemorrhaging, because hemorrhaging is 
merely a symptom of a disease. Therefore, it is the 
underlying cause, such as uterine atony or abruptio 
placentae, which will present with hemorrhage, but 
each of these conditions has a unique etiology. The 
risk of hemorrhage is increased in cases of multiple 
pregnancies, polyhydramnios, macrosomia, precipitous 
labor or prolonged labor, chorioamionitis, or simply the 
inability to contract the uterine muscle, due to the use 
of tocolytics or general anesthesia(12-13).
We note the definition of the underlying cause as 
“disease or injury which initiated a chain of events which 
leads to death,” which is the adopted terminology used 
in mortality statistics throughout the world(4,15). This is 
also important because, in order to prevent, control, or 
intervene effectively in an obstetrical hemorrhage, it is 
necessary to know the underlying cause.
Thus in cases of MM, the underlying cause should 
be clearly recorded on the death certificate, and we 
recommend that bleeding not be listed as a “cause”, but 
that the underlying causes that triggered the bleeding 
such as: abruptio placentae, uterine atony, and others 
shown in Table 1, as presented in the CID-10 be 
recorded.
Postpartum hemorrhage
One main cause of postpartum death found in 
this study was uterine atony resulting in postpartum 
hemorrhage, a result that is consistent with other 
studies(8-9,11)..These findings are similar to those of the 
World Health Organization, who also find that the main 
cause of maternal mortality, responsible for one quarter 
of all maternal deaths, is obstetric hemorrhage that 
usually occurs after delivery, and can lead to death if 
care and treatment are not implemented to control the 
immediate hemorrhage(1,6-9).
MM due to hemorrhage is, in general, associated 
with a type of monitoring during labor and the postpartum 
period, delayed response to loss of blood, and lack of a 
blood bank being located in maternity(10-13). Most of these 
deaths occur within 24 hours and are greatly influenced 
by the non-recognition of potentially serious cases, as 
well as the inadequate structure of health services, for 
example, limited access to blood banks(18), in addition to 
other barriers to implementing a blood transfusion(19).
Implementation of protocols and standards
These cases would have a better prognosis if 
a standardized clinical protocol was adopted for the 
management of the third stage of labor (including 
appropriate cord clamping and administration of 10 units 
of oxytocin intramuscularly in the mother)(20-21). Using 
a standardized clinical protocol in cases of post-partum 
Table 2 - (continuation)
Year Brazil North Northeast Southeast South Midwest
2005 9.46 7.94 9.62 10.07 8.16 10.81
2006 9.64 7.56 10.59 9.65 9.23 9.92
2007 10.34 8.98 9.90 11.04 11.02 9.75
2008 8.28 9.94 8.44 7.61 7.81 8.53
2009 9.96 7.08 11.67 10.18 8.73 8.63
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hemorrhage and additional training of multidisciplinary 
teams may improve maternal outcomes(20). Increasing 
the availability of blood for transfusions and alternatives 
to transfusions, such as autologous transfusions before 
and during surgery or delivery, would also help reduce 
deaths(22).
Need for improved data collection/documentation
These regional differences may be related to the 
quality of information on death certificates, given that 
this is a well-recognized problem in most developing 
countries(1,12).
MM is the result of several determinants, and 
quantifying and analyzing it are affected by the 
inadequate filing and coding of death certificates. Thus, 
the data recorded in most developing countries should 
be analyzed for the possibility of underreporting and 
hidden information(2,9,23).
This may be related to technical inaccuracies in the 
medical certification of deaths and/or the poor quality of 
the institutional records (hospital charts and outpatient 
records), among other factors(4,9,15). Furthermore, 
studies of MM have variable coverage, depending on the 
type of record and the country to which it refers. But 
there is recognition of the likelihood of underreporting 
of MM (estimated between 20 and 50%) in all countries, 
including those who have developed specific ways to 
improve records and data collection(9).
In Brazil, the installation of Maternal Mortality 
Committees in all 27 states has improved the detection 
and reporting of MM, however, the quality of such reports 
has varied according to location and time of occurrence, 
affecting the interpretation of temporal trends and rates 
by regions(12).
In Brazil, there have been several initiatives to 
improve the collection of data on maternal mortality; 
for example, there has been a multicenter study that, 
among their results, developed a correction factor for 
Brazilian state capitals(15). Another initiative was the 
issuance of Resolution number 256, of the National 
Health Council, which requires that maternal death in 
states and municipalities be a notification event for 
epidemiological surveillance.
The average mortality rate in the first years of this 
study (starting in 1997) shows little significant change 
from the last years of this study (ending in 2007), 
which may be partially explained by improved reliability 
of data collection and better reporting, rather than an 
actual increase in incidence or lack of change. However, 
MM due to hemorrhage remains an avoidable crisis.
In summary, temporal trends in MMR show some 
improvement based on vital statistics, as well as 
providing evidence of a decline in the maternal mortality 
ratio in the last thirty years. However, the United 
Nations Millennium Development Goal Number 5 (calling 
for a 75% reduction in maternal mortality from 1990 
to 2015), may well not be reached(12). We must also 
be aware that the risk of a woman dying as a result of 
pregnancy or childbirth during her lifetime is about one 
in six in the poorest regions of the world, as compared 
to the rate of about one in 30,000 in Northern Europe. 
It is also important to reflect on the global commitment 
to reduce MM(24-25).
Mortality from hemorrhage, represented in the MMR, 
and verified in this study, is alarming and, due to the 
magnitude that it represents and also the vulnerability 
of otherwise healthy women and the implications for 
future generations, represents a significant public 
health problem. Simple measures such as the active 
management of the immediate postpartum period, early 
diagnosis, and better care for patients with hypertensive 
syndrome, can reduce mortality of this sort.
Conclusion
The Brazilian situation shows the regional inequalities 
regarding maternal mortality from hemorrhage, and this 
analysis reveals several opportunities to improve care 
for women in the perinatal period. Throughout the series 
(1997-2007), there was no significant reduction in MMR 
rates in any of the regions. The existence of technology 
to intervene in obstetric hemorrhaging has not led to 
the desired outcomes in Brazil. The results of this study 
demonstrate a need for change in clinical practice and in 
the management of postpartum hemorrhage and more 
attention to women’s health, in general.
Improved record keeping, including documenting 
on the death certificate the underlying condition 
that triggered the bleeding would help facilitate root 
cause analysis. Questions emerged from this data, 
demonstrating the need for improved data reporting. 
It is difficult to track trends or fluctuations if the data 
is suspect. However, poor record keeping does not 
explain away the problem. Consider that most births in 
Brazil occur in a hospital, and that the protocols for the 
management of obstetrical hemorrhage are known, and 
thus prevention is in the domain of the professionals that 
provide care. Further research and clinical innovation 
is clearly needed to address the problem of maternal 
mortality in Brazil.
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